Digestive System Diseases  >>  milategrast (E6007)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
milategrast (E6007) / Eisai
NCT01221818: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects

Completed
1
48
US
E6007
Eisai Inc.
Inflammatory Bowel Disease
10/11
 

Download Options